WallStSmart

Kenvue Inc. (KVUE)vsProcter & Gamble Company (PG)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Procter & Gamble Company generates 464% more annual revenue ($85.26B vs $15.12B). PG leads profitability with a 19.3% profit margin vs 9.7%. KVUE appears more attractively valued with a PEG of 1.50. KVUE earns a higher WallStSmart Score of 58/100 (C).

KVUE

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 8.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.22

PG

Buy

53

out of 100

Grade: C-

Growth: 5.3Profit: 9.0Value: 4.7Quality: 7.0
Piotroski: 4/9Altman Z: 3.01
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

KVUEUndervalued (+1.3%)

Margin of Safety

+1.3%

Fair Value

$18.79

Current Price

$17.43

$1.36 discount

UndervaluedFair: $18.79Overvalued
PGSignificantly Overvalued (-216.5%)

Margin of Safety

-216.5%

Fair Value

$45.76

Current Price

$146.71

$100.95 premium

UndervaluedFair: $45.76Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

KVUE0 strengths · Avg: 0/10

No standout strengths identified

PG6 strengths · Avg: 9.3/10
Market CapQuality
$354.54B10/10

Mega-cap, among the largest globally

Return on EquityProfitability
31.6%10/10

Every $100 of equity generates 32 in profit

Revenue GrowthGrowth
150.0%10/10

Revenue surging 150.0% year-over-year

Altman Z-ScoreHealth
3.0110/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
26.3%8/10

Strong operational efficiency at 26.3%

Free Cash FlowQuality
$3.81B8/10

Generating 3.8B in free cash flow

Areas to Watch

KVUE3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

PG2 concerns · Avg: 2.0/10
PEG RatioValuation
4.142/10

Expensive relative to growth rate

EPS GrowthGrowth
-5.4%2/10

Earnings declined 5.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : KVUE

KVUE has a balanced fundamental profile.

Bull Case : PG

The strongest argument for PG centers on Market Cap, Return on Equity, Revenue Growth. Profitability is solid with margins at 19.3% and operating margin at 26.3%. Revenue growth of 150.0% demonstrates continued momentum.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Piotroski F-Score, Altman Z-Score.

Bear Case : PG

The primary concerns for PG are PEG Ratio, EPS Growth.

Key Dynamics to Monitor

KVUE profiles as a value stock while PG is a growth play — different risk/reward profiles.

KVUE carries more volatility with a beta of 0.47 — expect wider price swings.

PG is growing revenue faster at 150.0% — sustainability is the question.

PG generates stronger free cash flow (3.8B), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (58/100 vs 53/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Procter & Gamble Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Procter & Gamble Company (P&G) is an American multinational consumer goods corporation headquartered in Cincinnati, Ohio, founded in 1837 by William Procter and James Gamble. It specializes in a wide range of personal health, consumer health, personal care, and hygiene products; these products are organized into several segments including Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine, & Family Care. Before the sale of Pringles to Kellogg's, its product portfolio also included food, snacks, and beverages.

Visit Website →

Want to dig deeper into these stocks?